International Stem Cell Corporation
06/12/2026 | Press release | Distributed by Public on 06/12/2026 05:58
Proxy Results (Form 8-K)
ITEM 5.07 Submission of Matters to a Vote of Security Holders
International Stem Cell Corporation (the "Company") held its Annual Meeting of Stockholders on June 11, 2026. The stockholders considered one proposal, which is described in more detail in the Company's definitive proxy statement dated April 24, 2026.
| Proposal 1: | Election of four directors to hold office until the 2027 Annual Meeting: |
| A. | Directors elected by holders of Series D Preferred Stock: |
| FOR | WITHHELD | |||
| Andrey Semechkin | 2,457,143 | 0 | ||
| Russell Kern | 2,457,143 | 0 |
| B. | Directors elected by holders of all shares of stock (including shares of preferred stock voting on an as-converted basis): |
| FOR | WITHHELD | |||
| Donald A. Wright | 9,288,444 | 30,590 | ||
| Paul V. Maier | 9,288,500 | 30,534 |
Broker Non-Votes: none
All of the foregoing candidates were elected.
International Stem Cell Corporation published this content on June 12, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 12, 2026 at 11:58 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]